Empagliflozin as an Adjunct to Insulin Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Impact of Empagliflozin Added on to Basal Insulin in Type 2 Diabetes Inadequately Controlled on Basal Insulin: A 78-Week Randomized, Double-Blind, Placebo-Controlled Trial
Diabetes Obes Metab 2015 Oct 01;17(10)936-948, J Rosenstock, A Jelaska, C Zeller, G Kim, UC Broedl, HJ WoerleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.